Traitement de l’endométriose par les inhibiteurs de l’aromatase : efficacité thérapeutique et conséquences osseuses

A.-C. Racine; A-C Racine; E Legrand; Érick Legrand; C Lefebvre-Lacoeuille; C. Lefebvre-Lacœuille; E Hoppe; E. Hoppé; L Catala; Loı̈c Sentilhes; L Sentilhes; P Descamps

doi:10.1016/j.gyobfe.2010.03.005

Traitement de l’endométriose par les inhibiteurs de l’aromatase : efficacité thérapeutique et conséquences osseuses

A.-C. Racine, A-C Racine, E Legrand, Érick Legrand, C Lefebvre-Lacoeuille, C. Lefebvre-Lacœuille, E Hoppe, E. Hoppé, L Catala, Loı̈c Sentilhes, L Sentilhes, P Descamps

Gynecologie, obstetrique & fertilite · 2010 · vol. 38(5) , pp. 318–323 · doi:10.1016/j.gyobfe.2010.03.005 · PMID:20430665 · W2154599588

review OA: closed CC0 ⤵ 6 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This paper reviews the therapeutic efficacy and bone-related consequences of using aromatase inhibitors to treat endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Aromatase Inhibitors Aromatase Inhibitors Endometriosis Osteoporosis Aromatase Aromatase Aromatase Inhibitors Contraceptives, Oral Contraceptives, Oral Drug Therapy, Combination Endometriosis Endometriosis Endometriosis Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Osteoporosis Pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (43)

Advances in the management of endometriosis: an update for clinicians via openalex
Advances in the medical management of endometriosis via openalex
Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis via openalex
Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: New questions—old answers? via openalex
Aromatase Inhibitors in the Treatment of Severe Endometriosis via openalex
Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists via openalex
Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex
Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist via openalex
Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis via openalex
EPIDEMIOLOGY OF ENDOMETRIOSIS via openalex
Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. via openalex
Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septum via openalex
Genetic or Enzymatic Disruption of Aromatase Inhibits the Growth of Ectopic Uterine Tissue via openalex
Genetic or Enzymatic Disruption of Aromatase Inhibits the Growth of Ectopic Uterine Tissue via openalex
Letrozole and norethisterone acetate in rectovaginal endometriosis via openalex
Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor via openalex
Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex
Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study via openalex
Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor via openalex
Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients via openalex
Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor via openalex
Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis via openalex
The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial via openalex
The Epidemiology of Pelvic Endometriosis via openalex
Treatment of pelvic pain associated with endometriosis via openalex
Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor via openalex
Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman via openalex
W2159803441 via openalex
W4206164949 via openalex
W4236627566 via openalex
W1976680910 via openalex
W1967877758 via openalex
W4285719527 via openalex
W2092174240 via openalex
W2109525253 via openalex
W2121656289 via openalex
W2139959697 via openalex
W2145213731 via openalex
W2146194560 via openalex
W2151447010 via openalex
W2047289419 via openalex
W2157853773 via openalex

Cited by (6)

Source provenance

europepmc: last seen: 2026-06-11T06:19:48.454388+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:17:12.951333+00:00

License: CC0 · commercial use OK

[1] Advances in the management of endometriosis: an update for clinicians via openalex

[2] Advances in the medical management of endometriosis via openalex

[3] Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex

[4] Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis via openalex

[5] Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: New questions—old answers? via openalex

[6] Aromatase Inhibitors in the Treatment of Severe Endometriosis via openalex

[7] Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists via openalex

[8] Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex

[9] Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist via openalex

[10] Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis via openalex

[11] EPIDEMIOLOGY OF ENDOMETRIOSIS via openalex

[12] Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. via openalex

[13] Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septum via openalex

[14] Genetic or Enzymatic Disruption of Aromatase Inhibits the Growth of Ectopic Uterine Tissue via openalex

[15] Genetic or Enzymatic Disruption of Aromatase Inhibits the Growth of Ectopic Uterine Tissue via openalex

[16] Letrozole and norethisterone acetate in rectovaginal endometriosis via openalex

[17] Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor via openalex

[18] Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex

[19] Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study via openalex

[20] Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor via openalex

[21] Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients via openalex

[22] Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor via openalex

[23] Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis via openalex

[24] The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial via openalex

[25] The Epidemiology of Pelvic Endometriosis via openalex

[26] Treatment of pelvic pain associated with endometriosis via openalex

[27] Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor via openalex

[28] Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman via openalex

[29] W2159803441 via openalex

[30] W4206164949 via openalex

[31] W4236627566 via openalex

[32] W1976680910 via openalex

[33] W1967877758 via openalex

[34] W4285719527 via openalex

[35] W2092174240 via openalex

[36] W2109525253 via openalex

[37] W2121656289 via openalex

[38] W2139959697 via openalex

[39] W2145213731 via openalex

[40] W2146194560 via openalex

[41] W2151447010 via openalex

[42] W2047289419 via openalex

[43] W2157853773 via openalex